Over the past few years, entrepreneurs, investors, and stockholders from the business community have been keenly interested in the psychedelic medicine market. The market is expected to grow more than 10 billion by 2027. Psychedelic companies are working to make psychedelic medicine commercially accessible to treat conditions like PTSD, depression, and chronic pain. Creating a startup in […]
Starting a business startup is a big accomplishment; however, operating it successfully is the biggest test most business people fail. Over two-thirds of new startups fail, and end and most of these ventures end in the first three years. Operating in a psychedelic medicine industry can be very challenging due to the taboo around psychedelic drug […]
Alzheimer’s disease is one of the most prevalent cognitive diseases in the world with more than 30 million global cases. It affects your motor skills and function, memory and attention span, and self-control, causing a gradual cognitive decline.
Every business needs to have key performance indicators (KPIs) to measure its growth and progress. However, many new ventures struggle to meet their KPI targets which impacts their business’s success. Here’s why your psychedelic startup is struggling to meet KPI targets.
Psychedelic drugs have been the subject of all sorts of myths and misconceptions. From being dismissed as solely recreational drugs to being categorized as dangerous, they’ve been stigmatized by health professionals, regulatory bodies, and consumers alike. Here are a few common myths about psychedelics that you shouldn’t believe.